Biopharmaceutical Company's Stock Plunges 75% After FDA Rejects New Drug 0 30.11.2024 02:20 International Business Times Applied Therapeutics' stock plummeted 75 percent after the Food and Drug Administration (FDA) rejected approving govorestat as a treatment for galactosemia. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
